Displaying all 3 publications

Abstract:
Sort:
  1. Abd Hamid MR, Tai ELM, Wan Hazabbah WH, Ramli N
    J Allergy Clin Immunol Pract, 2019 Apr;7(4):1308-1309.
    PMID: 30581132 DOI: 10.1016/j.jaip.2018.11.016
    Matched MeSH terms: Ophthalmic Solutions/therapeutic use*
  2. Graham JE, McGilligan VE, Berrar D, Leccisotti A, Moore JE, Bron AJ, et al.
    Ophthalmic Res, 2010;43(1):11-7.
    PMID: 19829007 DOI: 10.1159/000246573
    AIM: The purpose of this study was to survey the attitudes of optometrists and ophthalmologists, located in a number of different countries, towards diagnostic tests and therapies for dry eye disease.
    METHODS: A web-based questionnaire was used to survey attitudes using forced-choice questions and Likert scales.
    RESULTS: Sixty-one respondents (23 ophthalmologists and 38 optometrists) reported a wide range of patient dry eye symptoms. A large variation in use of diagnostic tests was noted. Patient symptoms and fluorescein staining were reported to be significantly more valuable and more frequently performed than any other test. Artificial tear supplements and improved lid hygiene were the preferred therapeutic options selected by the entire group. The results demonstrated a wide variation in attitudes in relation to satisfaction with the range of available diagnostic and therapeutic options.
    CONCLUSIONS: This study indicates that the interest for the issue of dry eye is relatively limited amongst eye professionals, as demonstrated by the poor participation in the questionnaire.
    Matched MeSH terms: Ophthalmic Solutions/therapeutic use
  3. Neoh CF, Daniell M, Chen SC, Stewart K, Kong DC
    Int J Antimicrob Agents, 2014 Aug;44(2):96-104.
    PMID: 24933448 DOI: 10.1016/j.ijantimicag.2014.04.008
    Treatment of fungal keratitis remains challenging. To date, only the polyenes and azoles are commonly used topically in the management of fungal keratitis. Natamycin, a polyene, is the only antifungal eye drop that is commercially available; the remainder are prepared in-house and are used in an 'off-label' manner. Failure of medical treatment for fungal keratitis is common, hence there is a need for more effective topical antifungal therapy. To increase the antifungal eye drop armamentarium, it is important to investigate the utility of other classes of antifungal agents for topical use. Caspofungin, an echinocandin antifungal agent, could potentially be used to address the existing shortcomings. However, little is known about the usefulness of topically administered caspofungin. This review will briefly explore the incidence, epidemiology and antifungal treatment of fungal keratitis. It will focus primarily on evidence related to the efficacy, safety and practicality of using caspofungin eye drops in fungal keratitis.
    Matched MeSH terms: Ophthalmic Solutions/therapeutic use
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links